Mutations in the human protein palmitoyl thioesterase-1 (PPT-1) gene result in an autosomal recessive neurodegenerative disorder designated neuronal ceroid lipofuscinosis (NCL), type CLN1, or infantile NCL. Among the symptoms of the CLN1 disease are accumulation of autofluorescent lysosomal storage bodies in neurons and other cell types, seizures, motor and cognitive decline, blindness, and premature death. Development of an effective therapy for this disorder will be greatly assisted by the availability of suitable animal models. A mouse PPT-1 gene knockout model has recently been generated. Studies were performed to determine whether the mouse model exhibits ocular features of the human CLN1 disorder. A progressive accumulation of autofluorescent storage material in all layers of the retina was observed in the PPT-1 knockout mice. Accompanying the storage body accumulation was a modest loss of cells with nuclei in the outer and inner nuclear layers. As indicated by electroretinogram (ERG) responses, retinal function was only mildly impaired at 4 months of age but was severely impaired by 8 months, despite only modest changes in retinal morphology. The pupillary light reflex (PLR), on the other hand, was exaggerated in the knockout mice. The apparent anomaly between the ERG and the PLR findings suggests that disease-related PLR changes may be due to changes in extraocular signal processing. The pronounced ocular phenotype in the PPT-1 knockout mice makes these animals a good model for testing therapeutic interventions for treatment of the human CLN1 disorder.
KeywordsBatten; retinal degeneration; animal model; electroretinogram; pupillary light reflex The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited neurodegenerative disorders characterized by vision loss, seizures, cognitive and motor decline, and premature death (Wisniewski et al., 2001). All of the NCLs are characterized by massive accumulations of autofluorescent lysosomal storage bodies in neurons and other cell types (Jolly and Palmer, 1995;Katz et al., 1997;Wisniewski et al., 2001). The NCLs have long been classified into a number of different forms based on differences in clinical signs, such as the age of symptom onset, pattern of symptoms, and rate of disease progression. Since : CLN1 (PPT1), CLN2 (TPP1), CLN3, CLN5, CLN6, and CLN8 (Mole, 1999;Wisniewski et al., 2001). The disease with the earliest onset, infantile NCL, or CLN1, was found to result from mutations in the gene encoding the lysosomal enzyme palmitoyl protein thioesterase-1 (PPT1; Vesa et al., 1995). A mouse CLN1 gene knockout model was subsequently developed by Hofmann and colleagues (Gupta et al., 2001). Although some phenotypic characterization of this model has been completed, the effects of the CLN1 mutation on the eye and visual system have not been thoroughly characterized. Because of the prominence of visual impairment in the NCLs, analyses were performed to characterize the consequences of the CLN1 knockout mutation on the visual system. The goal of th...